HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Betzana Zambrano Selected Research

Whooping Cough (Pertussis)

11/2017A Randomized Controlled Study of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine for Primary and Booster Vaccinations of Healthy Infants and Toddlers in Latin America.
10/2012A fully liquid DTaP-IPV-Hep B-PRP-T hexavalent vaccine for primary and booster vaccination of healthy Mexican children.
8/2012Safety and immunogenicity of an investigational fully liquid hexavalent DTaP-IPV-Hep B-PRP-T vaccine at two, four and six months of age compared with licensed vaccines in Latin America.
6/2011Immunogenicity and safety of an investigational hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-hepatitis B-Haemophilus influenzae B conjugate combined vaccine in healthy 2-, 4-, and 6-month-old Argentinean infants.
9/2003Immunological priming of one dose of inactivated hepatitis A vaccine given during the first year of life in presence of maternal antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Betzana Zambrano Research Topics

Disease

19Dengue (Dengue Fever)
01/2022 - 01/2011
6Diphtheria
05/2023 - 06/2011
6Hepatitis B
11/2017 - 04/2010
6Tetanus
11/2017 - 09/2003
5Whooping Cough (Pertussis)
11/2017 - 09/2003
4Infections
01/2021 - 01/2015
2Severe Dengue
01/2021 - 09/2015
2Poliomyelitis (Polio)
11/2017 - 09/2003
1COVID-19
12/2023
1Meningococcal Infections
05/2023
1Diarrhea
01/2015
1Japanese Encephalitis
01/2014
1Yellow Fever
09/2012
1Pain (Aches)
01/2011
1Headache (Headaches)
01/2011
1Myalgia
01/2011

Drug/Important Bio-Agent (IBA)

18VaccinesIBA
12/2023 - 09/2003
13Dengue VaccinesIBA
01/2022 - 01/2011
5Neutralizing AntibodiesIBA
01/2021 - 09/2012
5Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate (ActHIB)IBA
11/2017 - 06/2011
3AntigensIBA
07/2015 - 08/2012
3Combined VaccinesIBA
08/2012 - 04/2010
2Immunoglobulin G (IgG)IBA
01/2021 - 07/2018
2Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2018
2Pertussis VaccineIBA
10/2013 - 08/2012
2Hemagglutinins (Hemagglutinin)IBA
10/2012 - 01/2012
1Tetanus Toxoid (Vaccine, Tetanus)FDA Link
05/2023
1Conjugate VaccinesIBA
05/2023
1CYD-TDV vaccineIBA
01/2019
1EnzymesIBA
07/2018
1ImmunosorbentsIBA
07/2018
1AntipyreticsIBA
11/2017
1Anti-Bacterial Agents (Antibiotics)IBA
01/2015
1DNA Restriction Enzymes (Restriction Endonuclease)IBA
01/2015
1ChimeriVaxIBA
01/2014
1Pertussis ToxinIBA
10/2012
1antineoplaston A10 (A 10)IBA
09/2012
1RibitolIBA
01/2012
1pertussis toxoidIBA
01/2012
1Phosphates (Orthophosphate)IBA
01/2012
1Surface Antigens (Surface Antigen)IBA
06/2011
1DTaP-IPV-HB-PRP-T vaccineIBA
06/2011
1PentavacIBA
06/2011
1Hepatitis A Vaccines (Hepatitis A Vaccine)IBA
09/2003

Therapy/Procedure

3Injections
10/2016 - 01/2011